Oxidative stress in preeclampsia and the role of free fetal hemoglobin

Frontiers in Physiology

Volumn 6, Issue JAN, 2015, Pages

  Hansson, Stefan R ^a   Nääv, Åsa ^a   Erlandsson, Lena ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Alpha 1 microglobulin; Fetal hemoglobin; Hemolysis; Oxidative stress; Placenta

Indexed keywords

ALPHA 1 MICROGLOBULIN; ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; ENDOTHELIN 1; FERROUS ION; FIBRONECTIN; HEME OXYGENASE; HEMOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

BLOOD PLACENTA BARRIER; CYTOKINE PRODUCTION; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FETUS; FETUS BLOOD; FETUS CIRCULATION; GENE EXPRESSION PROFILING; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY INJURY; LEUKOCYTE ACTIVATION; MACROPHAGE MIGRATION; MITOCHONDRIAL RESPIRATION; MOLECULAR PATHOLOGY; NITRATIVE STRESS; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PLACENTA DISORDER; PREECLAMPSIA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK REDUCTION; VITAMIN SUPPLEMENTATION;

EID: 84926465859     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00516     Document Type: Review

References (158)

1. Ademuyiwa, O., Odusoga, O. L., Adebawo, O. O., and Ugbaja, R. (2007). Endogenous antioxidant defences in plasma and erythrocytes of pregnant women during different trimesters of pregnancy. Acta Obstet. Gynecol. Scand. 86, 1175-1182. doi: 10.1080/00016340701515357
2. Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., and Gupta, S. (2012). The effects of oxidative stress on female reproduction: a review. Reprod. Biol. Endocrinol. 10:49. doi: 10.1186/1477-7827-10-49
3. Akerstrom, B., and Gram, M. (2014). A1M, an extravascular tissue cleaning and housekeeping protein. Free Radic. Biol. Med. 74C, 274-282. doi: 10.1016/j.freeradbiomed.2014.06.025
4. Ali Akbar, S., Nicolaides, K. H., and Brown, P. R. (1998). Measurement of Cu/Zn SOD in placenta, cultured cells, various fetal tissues, decidua and semen by ELISA. J. Obstet. Gynaecol. 18, 331-335. doi: 10.1080/01443619867056
5. Allhorn, M., Berggard, T., Nordberg, J., Olsson, M. L., and Akerstrom, B. (2002). Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99, 1894-1901. doi: 10.1182/blood.V99.6.1894
6. Ames, B. N., Cathcart, R., Schwiers, E., and Hochstein, P. (1981). Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U.S.A. 78, 6858-6862. doi: 10.1073/pnas.78.11.6858
7. Ariza, A. C., Bobadilla, N. A., and Halhali, A. (2007). [Endothelin 1 and angiotensin II in preeeclampsia]. Rev. Invest. Clin. 59, 48-56.
8. Arredondo, M., and Nunez, M. T. (2005). Iron and copper metabolism. Mol. Aspects Med. 26, 313-327. doi: 10.1016/j.mam.2005.07.010
9. Ascenzi, P., Bocedi, A., Visca, P., Altruda, F., Tolosano, E., Beringhelli, T., et al. (2005). Hemoglobin and heme scavenging. IUBMB Life 57, 749-759. doi: 10.1080/15216540500380871
10. Becker, B. F. (1993). Towards the physiological function of uric acid. Free Radic. Biol. Med. 14, 615-631. doi: 10.1016/0891-5849(93)90143-I
11. Belcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., et al. (2014). Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood 123, 377-390. doi: 10.1182/blood-2013-04-495887
12. Belenky, P., Bogan, K. L., and Brenner, C. (2007). NAD+ metabolism in health and disease. Trends Biochem. Sci. 32, 12-19. doi: 10.1016/j.tibs.2006.11.006
13. Berg, C. J., Mackay, A. P., Qin, C., and Callaghan, W. M. (2009). Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet. Gynecol. 113, 1075-1081. doi: 10.1097/AOG.0b013e3181a09fc0
14. Brophy, M. H., Harris, N. F., and Crawford, I. L. (1985). Elevated copper and lowered zinc in the placentae of pre-eclamptics. Clin. Chim. Acta 145, 107-111. doi: 10.1016/0009-8981(85)90024-5
15. Brosens, J. J., Pijnenborg, R., and Brosens, I. A. (2002). The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am. J. Obstet. Gynecol. 187, 1416-1423. doi: 10.1067/mob.2002.127305
16. Buehler, P. W., and D'Agnillo, F. (2010). Toxicological consequences of extracellular hemoglobin: biochemical and physiological perspectives. Antioxid. Redox Signal. 12, 275-291. doi: 10.1089/ars.2009.2799
17. Buhimschi, I. A., Nayeri, U. A., Zhao, G., Shook, L. L., Pensalfini, A., Funai, E. F., et al. (2014). Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci. Transl. Med. 6, 245ra92. doi: 10.1126/scitranslmed.3008808
18. Bunn, H. F., Forget, B. G., and Ranney, H. M. (1977). Hemoglobinopathies. Major Probl. Intern. Med. 12, 1-291.
19. Buonocore, G., Perrone, S., and Tataranno, M. L. (2010). Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin. Fetal Neonatal Med. 15, 186-190. doi: 10.1016/j.siny.2010.04.003
20. Burton, G. J., Yung, H. W., Cindrova-Davies, T., and Charnock-Jones, D. S. (2009). Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta 30, S43-S48. doi: 10.1016/j.placenta.2008.11.003
21. Cackovic, M., Buhimschi, C. S., Zhao, G., Funai, E. F., Norwitz, E. R., Kuczynski, E., et al. (2008). Fractional excretion of tumor necrosis factor-alpha in women with severe preeclampsia. Obstet. Gynecol. 112, 93-100. doi: 10.1097/AOG.0b013e31817c4304
22. Carlstrom, M., Persson, A. E., Larsson, E., Hezel, M., Scheffer, P. G., Teerlink, T., et al. (2011). Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension. Cardiovasc. Res. 89, 574-585. doi: 10.1093/cvr/cvq366
23. Centlow, M., Carninci, P., Nemeth, K., Mezey, E., Brownstein, M., and Hansson, S. R. (2008). Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil. Steril. 90, 1834-1843. doi: 10.1016/j.fertnstert.2007.09.030
24. Centlow, M., Junus, K., Nystrom, H., May, K., Larsson, I., Olsson, M. G., et al. (2009). Perfusion of the human placenta with red blood cells and xanthine oxidase mimics preeclampsia in-vitro. Z. Geburtshilfe Neonatol. 213, 89-95. doi: 10.1055/s-0029-1224196
25. Chelikani, P., Fita, I., and Loewen, P. C. (2004). Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 61, 192-208. doi: 10.1007/s00018-003-3206-5
26. Cindrova-Davies, T. (2014). The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia. Front. Pharmacol. 5:119. doi: 10.3389/fphar.2014.00119
27. Clark, D. E., Smith, S. K., He, Y., Day, K. A., Licence, D. R., Corps, A. N., et al. (1998). A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol. Reprod. 59, 1540-1548. doi: 10.1095/biolreprod59.6.1540
28. Conde-Agudelo, A., Althabe, F., Belizan, J. M., and Kafury-Goeta, A. C. (1999). Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am. J. Obstet. Gynecol. 181, 1026-1035. doi: 10.1016/S0002-9378(99)70341-8
29. Conde-Agudelo, A., Romero, R., Kusanovic, J. P., and Hassan, S. S. (2011). Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am. J. Obstet. Gynecol. 204, 503.e1-503.12. doi: 10.1016/j.ajog.2011.02.020
30. Cottrell, E., Garrod, A., Wareing, M., Dilworth, M., Finn-Sell, S., Greenwood, S., et al. (2014). Supplementation with inorganic nitrate during pregnancy improves maternal uterine artery function and placental efficiency in mice. Placenta 35, A21. doi: 10.1016/j.placenta.2014.06.071
31. Craici, I. M., Wagner, S. J., Bailey, K. R., Fitz-Gibbon, P. D., Wood-Wentz, C. M., Turner, S. T., et al. (2013). Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study. Hypertension 61, 1289-1296. doi: 10.1161/HYPERTENSIONAHA.113.01115
32. Cronqvist, T., Salje, K., Familari, M., Guller, S., Schneider, H., Gardiner, C., et al. (2014). Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia. PLoS ONE 9:e90020. doi: 10.1371/journal.pone.0090020
33. Dawson, E. B., Evans, D. R., and Nosovitch, J. (1999). Third-trimester amniotic fluid metal levels associated with preeclampsia. Arch. Environ. Health 54, 412-415. doi: 10.1080/00039899909603372
34. Dechend, R., Gratze, P., Wallukat, G., Shagdarsuren, E., Plehm, R., Brasen, J. H., et al. (2005). Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 45, 742-746. doi: 10.1161/01.HYP.0000154785.50570.63
35. Deng, L., Bremme, K., Hansson, L. O., and Blomback, M. (1994). Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet. Gynecol. 84, 941-945.
36. Di Santo, S., Sager, R., Andres, A. C., Guller, S., and Schneider, H. (2007). Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia. Placenta 28, S23-S32. doi: 10.1016/j.placenta.2007.01.009
37. Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., et al. (2003). Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707-716. doi: 10.1172/JCI17423
38. Fakhouri, F., Vercel, C., and Fremeaux-Bacchi, V. (2012). Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin. J. Am. Soc. Nephrol. 7, 2100-2106. doi: 10.2215/CJN.13121211
39. Gambling, L., Andersen, H. S., and McArdle, H. J. (2008). Iron and copper, and their interactions during development. Biochem. Soc. Trans. 36, 1258-1261. doi: 10.1042/BST0361258
40. Garovic, V. D., Wagner, S. J., Turner, S. T., Rosenthal, D. W., Watson, W. J., Brost, B. C., et al. (2007). Urinary podocyte excretion as a marker for preeclampsia. Am. J. Obstet. Gynecol. 196, 320.e1-320.e7. doi: 10.1016/j.ajog.2007.02.007
41. Goldenberg, R. L., Tamura, T., Neggers, Y., Copper, R. L., Johnston, K. E., Dubard, M. B., et al. (1995). The effect of zinc supplementation on pregnancy outcome. JAMA 274, 463-468. doi: 10.1001/jama.1995.03530060037030
42. Guerci, P., Vial, F., Feugeas, J., Pop, M., Baka, N. E., Bouaziz, H., et al. (2014). Cerebral oximetry assessed by near-infrared spectrometry during preeclampsia: an observational study: a preliminary study of the impact of magnesium sulfate administration. Crit. Care Med. 42, 2379-2386. doi: 10.1097/CCM.0000000000000519
43. Hahn, S., and Holzgreve, W. (2002). Fetal cells and cell-free fetal DNA in maternal blood: new insights into pre-eclampsia. Hum. Reprod. Update 8, 501-508. doi: 10.1093/humupd/8.6.501
44. Han, L., and Zhou, S. M. (1994). Selenium supplement in the prevention of pregnancy induced hypertension. Chin. Med. J. 107, 870-871.
45. Henao, D. E., Arias, L. F., Mathieson, P. W., Ni, L., Welsh, G. I., Bueno, J. C., et al. (2008). Preeclamptic sera directly induce slit-diaphragm protein redistribution and alter podocyte barrier-forming capacity. Nephron Exp. Nephrol. 110, e73-e81. doi: 10.1159/000166993
46. Henao, D. E., and Saleem, M. A. (2013). Proteinuria in preeclampsia from a podocyte injury perspective. Curr. Hypertens. Rep. 15, 600-605. doi: 10.1007/s11906-013-0400-1
47. Heydarian, M., McCaffrey, T., Florea, L., Yang, Z., Ross, M. M., Zhou, W., et al. (2009). Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta 30, 250-255. doi: 10.1016/j.placenta.2008.12.010
48. Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W., Carrington, M., Trowsdale, J., et al. (2004). Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965. doi: 10.1084/jem.20041214
49. Holmgren, A. (1989). Thioredoxin and glutaredoxin systems. J. Biol. Chem. 264, 13963-13966.
50. Hsu, C. D., Iriye, B., Johnson, T. R., Witter, F. R., Hong, S. F., and Chan, D. W. (1993). Elevated circulating thrombomodulin in severe preeclampsia. Am. J. Obstet. Gynecol. 169, 148-149. doi: 10.1016/0002-9378(93)90151-8
51. Huang, S. J., Chen, C. P., Schatz, F., Rahman, M., Abrahams, V. M., and Lockwood, C. J. (2008). Pre-eclampsia is associated with dendritic cell recruitment into the uterine decidua. J. Pathol. 214, 328-336. doi: 10.1002/path.2257
52. Hubel, C. A. (1999). Oxidative stress in the pathogenesis of preeclampsia. Proc. Soc. Exp. Biol. Med. 222, 222-235. doi: 10.1046/j.1525-1373.1999.d01-139.x
53. Hughes, R. E. (1964). Reduction of dehydroasorbic acid by animal tissues. Nature 203, 1068-1069. doi: 10.1038/2031068a0
54. Izquierdo Alvarez, S., Castanon, S. G., Ruata, M. L., Aragues, E. F., Terraz, P. B., Irazabal, Y. G., et al. (2007). Updating of normal levels of copper, zinc and selenium in serum of pregnant women. J. Trace Elem. Med. Biol. 21, 49-52. doi: 10.1016/j.jtemb.2007.09.023
55. Jauniaux, E., Watson, A. L., Hempstock, J., Bao, Y. P., Skepper, J. N., and Burton, G. J. (2000). Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am. J. Pathol. 157, 2111-2122. doi: 10.1016/S0002-9440(10)64849-3
56. Jones, E. A., Wright, J. M., Rice, G., Buckley, B. T., Magsumbol, M. S., Barr, D. B., et al. (2010). Metal exposures in an inner-city neonatal population. Environ. Int. 36, 649-654. doi: 10.1016/j.envint.2010.04.007
57. Karumanchi, S. A., and Levine, R. J. (2010). How does smoking reduce the risk of preeclampsia? Hypertension 55, 1100-1101. doi: 10.1161/HYPERTENSIONAHA.109.148973
58. Karumanchi, S. A., and Lindheimer, M. D. (2008). Preeclampsia pathogenesis: "triple a rating"-autoantibodies and antiangiogenic factors. Hypertension 51, 991-992. doi: 10.1161/HYPERTENSIONAHA.107.100735
59. Kassie, G. M., Negussie, D., and Ahmed, J. H. (2014). Maternal outcomes of magnesium sulphate and diazepam use in women with severe pre-eclampsia and eclampsia in Ethiopia. Pharm. Pract. (Granada) 12:400. doi: 10.4321/S1886-36552014000200006
60. Kendall, R. L., and Thomas, K. A. (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10705-10709. doi: 10.1073/pnas.90.22.10705
61. Kendall, R. L., Wang, G., and Thomas, K. A. (1996). Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226, 324-328. doi: 10.1006/bbrc.1996.1355
62. Kharitonova, M., Iezhitsa, I., Zheltova, A., Ozerov, A., Spasov, A., and Skalny, A. (2015). Comparative angioprotective effects of magnesium compounds. J. Trace Elem. Med. Biol. 29, 227-234. doi: 10.1016/j.jtemb.2014.06.026
63. Kikuchi, G., Yoshida, T., and Noguchi, M. (2005). Heme oxygenase and heme degradation. Biochem. Biophys. Res. Commun. 338, 558-567. doi: 10.1016/j.bbrc.2005.08.020
64. Kim-Shapiro, D. B., Schechter, A. N., and Gladwin, M. T. (2006). Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler. Thromb. Vasc. Biol. 26, 697-705. doi: 10.1161/01.ATV.0000204350.44226.9a
65. Knight, M., Redman, C. W., Linton, E. A., and Sargent, I. L. (1998). Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 105, 632-640. doi: 10.1111/j.1471-0528.1998.tb10178.x
66. Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H. J., Law, S. K., et al. (2001). Identification of the haemoglobin scavenger receptor. Nature 409, 198-201. doi: 10.1038/35051594
67. Kumar, S., and Bandyopadhyay, U. (2005). Free heme toxicity and its detoxification systems in human. Toxicol. Lett. 157, 175-188. doi: 10.1016/j.toxlet.2005.03.004
68. Kumru, S., Aydin, S., Simsek, M., Sahin, K., Yaman, M., and Ay, G. (2003). Comparison of serum copper, zinc, calcium, and magnesium levels in preeclamptic and healthy pregnant women. Biol. Trace Elem. Res. 94, 105-112. doi: 10.1385/BTER:94:2:105
69. Lafayette, R. A., Druzin, M., Sibley, R., Derby, G., Malik, T., Huie, P., et al. (1998). Nature of glomerular dysfunction in pre-eclampsia. Kidney Int. 54, 1240-1249. doi: 10.1046/j.1523-1755.1998.00097.x
70. Lang, F., Lang, E., and Foller, M. (2012). Physiology and pathophysiology of eryptosis. Transfus. Med. Hemother. 39, 308-314. doi: 10.1159/000342534
71. Lavrovsky, Y., Schwartzman, M. L., Levere, R. D., Kappas, A., and Abraham, N. G. (1994). Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. U.S.A. 91, 5987-5991. doi: 10.1073/pnas.91.13.5987
72. Lee, P. C., Roberts, J. M., Catov, J. M., Talbott, E. O., and Ritz, B. (2013). First trimester exposure to ambient air pollution, pregnancy complications and adverse birth outcomes in Allegheny County, PA. Matern. Child Health J. 17, 545-555. doi: 10.1007/s10995-012-1028-5
73. Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., et al. (2006). Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992-1005. doi: 10.1056/NEJMoa055352
74. Lockwood, C. J., Matta, P., Krikun, G., Koopman, L. A., Masch, R., Toti, P., et al. (2006). Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am. J. Pathol. 168, 445-452. doi: 10.2353/ajpath.2006.050082
75. Lowe, D. T. (2000). Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4, 441-458. doi: 10.1006/niox.2000.0296
76. Lundberg, J. O., Carlstrom, M., Larsen, F. J., and Weitzberg, E. (2011). Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc. Res. 89, 525-532. doi: 10.1093/cvr/cvq325
77. Lundberg, J. O., Weitzberg, E., and Gladwin, M. T. (2008). The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7, 156-167. doi: 10.1038/nrd2466
78. Mackay, A. P., Berg, C. J., and Atrash, H. K. (2001). Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 97, 533-538. doi: 10.1016/S0029-7844(00)01223-0
79. Madamanchi, N. R., Vendrov, A., and Runge, M. S. (2005). Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 29-38. doi: 10.1161/01.ATV.0000150649.39934.13
80. Malmqvist, E., Jakobsson, K., Tinnerberg, H., Rignell-Hydbom, A., and Rylander, L. (2013). Gestational diabetes and preeclampsia in association with air pollution at levels below current air quality guidelines. Environ. Health Perspect. 121, 488-493. doi: 10.1289/ehp.1205736
81. Markus, T., Hansson, S., Amer-Wahlin, I., Hellstrom-Westas, L., Saugstad, O. D., and Ley, D. (2007). Cerebral inflammatory response after fetal asphyxia and hyperoxic resuscitation in newborn sheep. Pediatr. Res. 62, 71-77. doi: 10.1203/PDR.0b013e31811ead6e
82. May, K., Rosenlof, L., Olsson, M. G., Centlow, M., Morgelin, M., Larsson, I., et al. (2011). Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by alpha1-microglobulin. Placenta 32, 323-332. doi: 10.1016/j.placenta.2011.01.017
83. McCord, J. M., and Fridovich, I. (1988). Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 5, 363-369. doi: 10.1016/0891-5849(88)90109-8
84. Messerli, M., May, K., Hansson, S. R., Schneider, H., Holzgreve, W., Hahn, S., et al. (2010). Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes. Placenta 31, 106-112. doi: 10.1016/j.placenta.2009.11.011
85. Minakami, H., Takahashi, T., Izumi, A., and Tamada, T. (1993). Increased levels of plasma thrombomodulin in preeclampsia. Gynecol. Obstet. Invest. 36, 208-210. doi: 10.1159/000292631
86. Mistry, H. D., and Williams, P. J. (2011). The importance of antioxidant micronutrients in pregnancy. Oxid. Med. Cell. Longev. 2011:841749. doi: 10.1155/2011/841749
87. Motterlini, R., Foresti, R., Vandegriff, K., Intaglietta, M., and Winslow, R. M. (1995). Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am. J. Physiol. 269, H648-H655.
88. Musci, T. J., Roberts, J. M., Rodgers, G. M., and Taylor, R. N. (1988). Mitogenic activity is increased in the sera of preeclamptic women before delivery. Am. J. Obstet. Gynecol. 159, 1446-1451. doi: 10.1016/0002-9378(88)90572-8
89. Myatt, L. (2010). Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31, S66-S69. doi: 10.1016/j.placenta.2009.12.021
90. Nordberg, J., and Arner, E. S. (2001). Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31, 1287-1312. doi: 10.1016/S0891-5849(01)00724-9
91. Nova, A., Sibai, B. M., Barton, J. R., Mercer, B. M., and Mitchell, M. D. (1991). Maternal plasma level of endothelin is increased in preeclampsia. Am. J. Obstet. Gynecol. 165, 724-727. doi: 10.1016/0002-9378(91)90317-K
92. Ogawa, K., Suzuki, K., Okutsu, M., Yamazaki, K., and Shinkai, S. (2008). The association of elevated reactive oxygen species levels from neutrophils with low-grade inflammation in the elderly. Immun. Ageing 5:13. doi: 10.1186/1742-4933-5-13
93. Olsson, M. G., Allhorn, M., Olofsson, T., and Akerstrom, B. (2007). Up-regulation of alpha1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and blood cell lines. Free Radic. Biol. Med. 42, 842-851. doi: 10.1016/j.freeradbiomed.2006.12.017
94. Olsson, M. G., Centlow, M., Rutardottir, S., Stenfors, I., Larsson, J., Hosseini-Maaf, B., et al. (2010). Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia. Free Radic. Biol. Med. 48, 284-291. doi: 10.1016/j.freeradbiomed.2009.10.052
95. Olsson, M. G., Olofsson, T., Tapper, H., and Akerstrom, B. (2008). The lipocalin alpha1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species. Free Radic. Res. 42, 725-736. doi: 10.1080/10715760802337265
96. Palmer, S. K., Moore, L. G., Young, D., Cregger, B., Berman, J. C., and Zamudio, S. (1999). Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am. J. Obstet. Gynecol. 180, 1161-1168. doi: 10.1016/S0002-9378(99)70611-3
97. Pereira, K. N., Knoppka, C. K., and Da Silva, J. E. (2014). Association between uric acid and severity of pre-eclampsia. Clin. Lab. 60, 309-314.
98. Pompella, A., Visvikis, A., Paolicchi, A., De Tata, V., and Casini, A. F. (2003). The changing faces of glutathione, a cellular protagonist. Biochem. Pharmacol. 66, 1499-1503. doi: 10.1016/S0006-2952(03)00504-5
99. Poston, L., Briley, A. L., Seed, P. T., Kelly, F. J., Shennan, A. H., and Vitamins In Pre-Eclampsia Trial, C. (2006). Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367, 1145-1154. doi: 10.1016/S0140-6736(06)68433-X
100. Poston, L., and Raijmakers, M. T. (2004). Trophoblast oxidative stress, antioxidants and pregnancy outcome-a review. Placenta 25, S72-S78. doi: 10.1016/j.placenta.2004.01.003
101. Raijmakers, M. T., Dechend, R., and Poston, L. (2004). Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 44, 374-380. doi: 10.1161/01.HYP.0000141085.98320.01
102. Rayman, M. P. (2009). Selenoproteins and human health: insights from epidemiological data. Biochim. Biophys. Acta 1790, 1533-1540. doi: 10.1016/j.bbagen.2009.03.014
103. Redman, C. W. (2011). Hypertension in pregnancy: the NICE guidelines. Heart 97, 1967-1969. doi: 10.1136/heartjnl-2011-300949
104. Redman, C. W., and Sargent, I. L. (2008). Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 29, S73-S77. doi: 10.1016/j.placenta.2007.11.016
105. Redman, C. W., and Sargent, I. L. (2009). Placental stress and pre-eclampsia: a revised view. Placenta 30(Suppl. A), S38-S42. doi: 10.1016/j.placenta.2008.11.021
106. Redman, C. W., and Sargent, I. L. (2010). Immunology of pre-eclampsia. Am. J. Reprod. Immunol. 63, 534-543. doi: 10.1111/j.1600-0897.2010.00831.x
107. Roberts, J. M., and Escudero, C. (2012). The placenta in preeclampsia. Pregnancy Hypertens. 2, 72-83. doi: 10.1016/j.preghy.2012.01.001
108. Roberts, J. M., and Hubel, C. A. (2009). The two stage model of preeclampsia: variations on the theme. Placenta, 30 Suppl. A, S32-S37. doi: 10.1016/j.placenta.2008.11.009
109. Roberts, J. M., Taylor, R. N., Musci, T. J., Rodgers, G. M., Hubel, C. A., and McLaughlin, M. K. (1989). Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161, 1200-1204. doi: 10.1016/0002-9378(89)90665-0
110. Rodgers, G. M., Taylor, R. N., and Roberts, J. M. (1988). Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am. J. Obstet. Gynecol. 159, 908-914. doi: 10.1016/S0002-9378(88)80169-8
111. Rodriguez, M., Moreno, J., and Hasbun, J. (2012). RAS in pregnancy and preeclampsia and eclampsia. Int. J. Hypertens. 2012:739274. doi: 10.1155/2012/739274
112. Rudov, A., Balduini, W., Carloni, S., Perrone, S., Buonocore, G., and Albertini, M. C. (2014). Involvement of miRNAs in placental alterations mediated by oxidative stress. Oxid. Med. Cell. Longev. 2014:103068. doi: 10.1155/2014/103068
113. Rumbold, A., Duley, L., Crowther, C. A., and Haslam, R. R. (2008). Antioxidants for preventing pre-eclampsia. Cochrane Database Syst. Rev. CD004227. doi: 10.1002/14651858.CD004227.pub3
114. Rumbold, A. R., Crowther, C. A., Haslam, R. R., Dekker, G. A., Robinson, J. S., and Group, A. S. (2006). Vitamins C and E and the risks of preeclampsia and perinatal complications. N. Engl. J. Med., 354, 1796-1806. doi: 10.1056/NEJMoa054186
115. Rumiris, D., Purwosunu, Y., Wibowo, N., Farina, A., and Sekizawa, A. (2006). Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertens. Pregnancy 25, 241-253. doi: 10.1080/10641950600913016
116. Rush, G. F., Gorski, J. R., Ripple, M. G., Sowinski, J., Bugelski, P., and Hewitt, W. R. (1985). Organic hydroperoxide-induced lipid peroxidation and cell death in isolated hepatocytes. Toxicol. Appl. Pharmacol. 78, 473-483. doi: 10.1016/0041-008X(85)90255-8
117. Rusterholz, C., Hahn, S., and Holzgreve, W. (2007). Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin. Immunopathol. 29, 151-162. doi: 10.1007/s00281-007-0071-6
118. Ryter, S. W., Alam, J., and Choi, A. M. (2006). Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650. doi: 10.1152/physrev.00011.2005
119. Salafia, C. M., Pezzullo, J. C., Lopez-Zeno, J. A., Simmens, S., Minior, V. K., and Vintzileos, A. M. (1995). Placental pathologic features of preterm preeclampsia. Am. J. Obstet. Gynecol. 173, 1097-1105. doi: 10.1016/0002-9378(95)91333-5
120. Sautin, Y. Y., and Johnson, R. J. (2008). Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 27, 608-619. doi: 10.1080/15257770802138558
121. Schneider, H., and Huch, A. (1985). Dual in vitro perfusion of an isolated lobe of human placenta: method and instrumentation. Contrib. Gynecol. Obstet. 13, 40-47.
122. Scholz, R. W., Graham, K. S., Gumpricht, E., and Reddy, C. C. (1989). Mechanism of interaction of vitamin E and glutathione in the protection against membrane lipid peroxidation. Ann. N.Y. Acad. Sci. 570, 514-517. doi: 10.1111/j.1749-6632.1989.tb14973.x
123. Schroeder, B. M. American College Of, O., and Gynecologists (2002). ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am. Fam. Physician 66, 330-331.
124. Sela, S., Itin, A., Natanson-Yaron, S., Greenfield, C., Goldman-Wohl, D., Yagel, S., et al. (2008). A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ. Res. 102, 1566-1574. doi: 10.1161/CIRCRESAHA.108.171504
125. Serdar, Z., Gur, E., and Develioglu, O. (2006). Serum iron and copper status and oxidative stress in severe and mild preeclampsia. Cell Biochem. Funct. 24, 209-215. doi: 10.1002/cbf.1235
126. Shmueli, A., Meiri, H., and Gonen, R. (2012). Economic assessment of screening for pre-eclampsia. Prenat. Diagn. 32, 29-38. doi: 10.1002/pd.2871
127. Sibai, B. M. (2005). Magnesium sulfate prophylaxis in preeclampsia: evidence from randomized trials. Clin. Obstet. Gynecol. 48, 478-488. doi: 10.1097/01.grf.0000160314.59736.d2
128. Smarason, A. K., Sargent, I. L., Starkey, P. M., and Redman, C. W. (1993). The effect of placental syncytiotrophoblast microvillous membranes from normal and pre-eclamptic women on the growth of endothelial cells in vitro. Br. J. Obstet. Gynaecol. 100, 943-949. doi: 10.1111/j.1471-0528.1993.tb15114.x
129. Sontia, B., and Touyz, R. M. (2007). Role of magnesium in hypertension. Arch. Biochem. Biophys. 458, 33-39. doi: 10.1016/j.abb.2006.05.005
130. Souza, A. S., Amorim, M. M., Coutinho, I. C., Lima, M. M., Noronha Neto, C., and Figueroa, J. N. (2010). Effect of the loading dose of magnesium sulfate (MgSO4) on the parameters of Doppler flow velocity in the uterine, umbilical and middle cerebral arteries in severe preeclampsia. Hypertens. Pregnancy 29, 123-134. doi: 10.3109/10641950902875772
131. Spinnato, J. A. II (2006). New therapies in the prevention of preeclampsia. Curr. Opin. Obstet. Gynecol. 18, 601-604. doi: 10.1097/01.gco.0000247393.86968.e6
132. Stillman, I. E., and Karumanchi, S. A. (2007). The glomerular injury of preeclampsia. J. Am. Soc. Nephrol. 18, 2281-2284. doi: 10.1681/ASN.2007020255
133. Strevens, H., Wide-Swensson, D., Hansen, A., Horn, T., Ingemarsson, I., Larsen, S., et al. (2003). Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 110, 831-836. doi: 10.1111/j.1471-0528.2003.02162.x
134. Sverrisson, K., Axelsson, J., Rippe, A., Gram, M., Akerstrom, B., Hansson, S. R., et al. (2014). Extracellular fetal hemoglobin induces increases in glomerular permeability: inhibition with alpha1-microglobulin and tempol. Am. J. Physiol. Renal Physiol. 306, F442-F448. doi: 10.1152/ajprenal.00502.2013
135. Tannetta, D. S., Dragovic, R. A., Gardiner, C., Redman, C. W., and Sargent, I. L. (2013). Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS ONE 8:e56754. doi: 10.1371/journal.pone.0056754
136. Taylor, R. N., Crombleholme, W. R., Friedman, S. A., Jones, L. A., Casal, D. C., and Roberts, J. M. (1991). High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone. Am. J. Obstet. Gynecol. 165, 895-901. doi: 10.1016/0002-9378(91)90435-T
137. Terzano, C., Di Stefano, F., Conti, V., Graziani, E., and Petroianni, A. (2010). Air pollution ultrafine particles: toxicity beyond the lung. Eur. Rev. Med. Pharmacol. Sci. 14, 809-821.
138. Thachil, J., and Toh, C. H. (2009). Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 23, 167-176. doi: 10.1016/j.blre.2009.04.002
139. Thomas, C. P., Andrews, J. I., Raikwar, N. S., Kelley, E. A., Herse, F., Dechend, R., et al. (2009). A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia. J. Clin. Endocrinol. Metab. 94, 2524-2530. doi: 10.1210/jc.2009-0017
140. Thorp, J. M. Jr., White, G. C. II., Moake, J. L., and Bowes, W. A. Jr. (1990). von Willebrand factor multimeric levels and patterns in patients with severe preeclampsia. Obstet. Gynecol. 75, 163-167.
141. Tjoa, M. L., Cindrova-Davies, T., Spasic-Boskovic, O., Bianchi, D. W., and Burton, G. J. (2006). Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am. J. Pathol. 169, 400-404. doi: 10.2353/ajpath,.2006.060161
142. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84. doi: 10.1016/j.biocel.2006.07.001
143. Vanderlelie, J., Venardos, K., Clifton, V. L., Gude, N. M., Clarke, F. M., and Perkins, A. V. (2005). Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 26, 53-58. doi: 10.1016/j.placenta.2004.04.002
144. Vigeh, M., Yokoyama, K., Ramezanzadeh, F., Dahaghin, M., Fakhriazad, E., Seyedaghamiri, Z., et al. (2008). Blood manganese concentrations and intrauterine growth restriction. Reprod. Toxicol. 25, 219-223. doi: 10.1016/j.reprotox.2007.11.011
145. Villar, J., Purwar, M., Merialdi, M., Zavaleta, N., Thi Nhu Ngoc, N., Anthony, J., et al. (2009). World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG 116, 780-788. doi: 10.1111/j.1471-0528.2009.02158.x
146. Wagner, S. J., Craici, I. M., Grande, J. P., and Garovic, V. D. (2012). From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia. Clin. Nephrol. 78, 241-249. doi: 10.5414/CN107321
147. Walsh, S. W. (1998). Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin. Reprod. Endocrinol. 16, 93-104. doi: 10.1055/s-2007-1016256
148. Walshe, T. E., Saint-Geniez, M., Maharaj, A. S., Sekiyama, E., Maldonado, A. E., and D'Amore, P. A. (2009). TGF-beta is required for vascular barrier function, endothelial survival and homeostasis of the adult microvasculature. PLoS ONE 4:e5149. doi: 10.1371/journal.pone.0005149
149. Wang, A., Rana, S., and Karumanchi, S. A. (2009). Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24, 147-158. doi: 10.1152/physiol.00043.2008
150. Wang, Y., and Walsh, S. W. (1996). Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J. Soc. Gynecol. Investig. 3, 179-184. doi: 10.1016/1071-5576(96)00015-9
151. Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M., Aboud, Z., Misra, S., et al. (2008). Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51, 784-790. doi: 10.1161/HYPERTENSIONAHA.107.103523
152. Wester-Rosenlof, L., Casslen, V., Axelsson, J., Edstrom-Hagerwall, A., Gram, M., Holmqvist, M., et al. (2014). A1M/alpha1-microglobulin protects from heme-induced placental and renal damage in a pregnant sheep model of preeclampsia. PLoS ONE 9:e86353. doi: 10.1371/journal.pone.0086353
153. Wimalasundera, R. C., Larbalestier, N., Smith, J. H., De Ruiter, A., McG Thom, S. A., Hughes, A. D., et al. (2002). Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet 360, 1152-1154. doi: 10.1016/S0140-6736(02)11195-0
154. Wolf, M., Kettyle, E., Sandler, L., Ecker, J. L., Roberts, J., and Thadhani, R. (2001). Obesity and preeclampsia: the potential role of inflammation. Obstet. Gynecol. 98, 757-762. doi: 10.1016/S0029-7844(01)01551-4
155. Wu, J., Ren, C., Delfino, R. J., Chung, J., Wilhelm, M., and Ritz, B. (2009). Association between local traffic-generated air pollution and preeclampsia and preterm delivery in the south coast air basin of California. Environ. Health Perspect. 117, 1773-1779. doi: 10.1289/ehp.0800334
156. Wu, J., Wilhelm, M., Chung, J., and Ritz, B. (2011). Comparing exposure assessment methods for traffic-related air pollution in an adverse pregnancy outcome study. Environ. Res. 111, 685-692. doi: 10.1016/j.envres.2011.03.008
157. Yung, H. W., Atkinson, D., Campion-Smith, T., Olovsson, M., Charnock-Jones, D. S., and Burton, G. J. (2014). Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia. J. Pathol. 234, 262-276. doi: 10.1002/path.4394
158. Zavalza-Gomez, A. B. (2011). Obesity and oxidative stress: a direct link to preeclampsia? Arch. Gynecol. Obstet. 283, 415-422. doi: 10.1007/s00404-010-1753-1